Compounds > 6-anilino-5,8-quinolinedione
Page last updated: 2024-10-30

6-anilino-5,8-quinolinedione and Asthma

6-anilino-5,8-quinolinedione has been researched along with Asthma in 1 studies

6-anilino-5,8-quinolinedione: structure given in first source; SRS-A & guanylate cyclase antagonist
6-anilino-5,8-quinolinedione : A quinolone that is quinoline-5,8-dione in which the hydrogen at position 6 is replaced by an anilino group.

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kageyama, N1
Miura, M1
Ichinose, M1
Tomaki, M1
Ishikawa, J1
Ohuchi, Y1
Endoh, N1
Shirato, K1

Other Studies

1 other study available for 6-anilino-5,8-quinolinedione and Asthma

ArticleYear
Role of endogenous nitric oxide in airway microvascular leakage induced by inflammatory mediators.
    The European respiratory journal, 1997, Volume: 10, Issue:1

    Topics: Aminoquinolines; Animals; Arginine; Asthma; Capillary Permeability; Coloring Agents; Dipeptides; Enz

1997